Eamonn Hobbs

Hobbs has more than 25 years experience in interventional radiology, interventional cardiology and the gastroenterology medical device industry. He is a bio-medical engineer, with a Bachelor of Sciences in Plastics Engineering with a Biomaterials emphasis from University of Massachusetts, Lowell. Mr. Hobbs started his career at Cook Incorporated. From 1983 to 1985, he was President and CEO, and Chairman of the Board of Hobbs Medical Inc., a medical device firm focused on interventional devices for gastroenterologists. He later served as a Vice President and Senior Vice-President of E-Z-EM, with operational responsibility for what would become AngioDynamics. Mr. Hobbs is also a member of the Board of Directors for the Society of Interventional Radiology Foundation. In 2005 he was granted an Honorary Fellowship from by the Society of Interventional Radiology and is the only member of the medical device industry to serve on the SIR strategic planning committee. He joined the Medical Device Manufacturers Association Board in 2005.

Joe Kiani

Joe E. Kiani is the founder, CEO and Chairman of the Board of Masimo Corporation. Mr. Kiani has held these positions since Masimo’s inception in 1989. Mr. Kiani is an inventor on more than 50 patents related to signal processing, sensors, and patient monitoring, including patents for the invention of motion and low-perfusion tolerant pulse oximetry. Prior to founding Masimo Corporation, Mr. Kiani served as regional technical manager for Anthem Electronics, and field applications engineer for Bell Industries, which distributed advanced semiconductor components. He serves on the Board of SABA, a publicly traded software company focused on Human Capital Development and Management solutions, Orange County Section of March of Dimes, and the Medical Device Manufacturers Association (MDMA). Mr. Kiani has a B.S.E.E. degree and an M.S.E.E. degree from San Diego State University.

Tom Burns

Tegra Medical
Vice President, Business Development

Tom joined Tegra Medical in 2008. He has had a long and varied career in the medical device industry and contract manufacturing.

Most recently, Tom was Vice President Sales & Marketing at Web Industries, a custom converter serving the medical and aerospace markets. Prior to that, he was with Accellent in varying capacities for nine years, holding the position of Vice President Sales & Marketing, Orthopaedic Division, for the last five years.

Accellent is a leading supplier of manufacturing services to the medical device industry. For the first fifteen years of his career, Tom held various sales and marketing jobs for several leaders in the medical device industry: Johnson & Johnson, Baxter Healthcare, and Genzyme Bio-Surgery.

He began his career with Whitehall Laboratories. Tom graduated with honors from Northeastern University with a B.S. in Marketing.

Tom Barrett

Keystone Dental

Senior Vice President of Manufacturing

Before he joined Keystone Dental, Tom held the position of Senior Vice President of Operations for Orthopedics and Endoscopy at Accelent Corporation. He also worked for Stryker Corporation for thirteen years, holding positions of increasing responsibility, including Vice President of Operations.

Tom has a degree in Mechanical Engineering from Union College, Schenectady, NY, and an MBA from Harvard Business School, Cambridge, MA.

Tegra Medical Unveils GENESIS Tech Center to Reduce Time to Market

Tegra Medical announced the formal opening of the GENESIS Tech Center (GTC), an 18,000 sq. ft. of refurbished space at Tegra’s new headquarters in Franklin, MA.    The GTC will address the medical device industry’s need for speed,  the GTC will be focused exclusively on assisting customers with their product development needs, specifically: inventory of commonly used raw materials for minimally invasive surgical and interventional products, design for manufacturability, prototyping and pilot production. Within the GENESIS Tech Center, there are three distinct offerings:

• Quick Wire & Tube: Inventory of the most commonly used wire and hypodermic tubing. Secondary processes are available with shipment in 3 days or less typically.
• Rapid Response Operation: Component and assembly fabrication in less than 2 weeks, just days in many cases, using laser processing, EDM, and a full assortment of conventional and CNC machining.
• Engineered Solutions: A team of experienced manufacturing engineers and project managers to tackle tough manufacturing challenges through DFM and innovative process development.

Tom Burns

“The GENESIS Tech Center is the answer to feedback we’ve heard consistently over the years,” said Tom Burns, V.P. Business Development. “Lots of suppliers talk about supporting product launches, but Tegra Medical is backing it up with some of our best talent, significant infrastructure and a culture intent upon solving customer problems fast. The GTC will be a stand-alone entity to avoid the conflicts inherent in trying to share resources with regular production operations.”

Tegra serves the following markets:

Orthopaedics

• Arthroscopic drivers
• Shavers
• Cannulae
• Burrs
• Stylets
• Knot pushers
• Spinal minimally invasive surgery instruments
• Interventional spine accessories
• K wires

Minimally Invasive Surgery

• Breast Biopsy systems
• Bariatric surgery
• Laparoscopic devices
• Endoscopic devices

Interventional Therapies

• Suturing device components
• Clip applier components
• Guide wires
• Introducers
• Mandrels

Drug Delivery

• Diabetes therapy
• Pain management
• Huber needles
• Epidural needles
• Spinal needles

Other Medical Specialties

• Ophthalmology needles
• Dental instruments

According to a Boston Scientific press release:

He led the orthopedics company Zimmer Holdings Inc. for 10 years, joining the company as President and rising to become Chairman, President and CEO.

Prior to joining Zimmer, he served as President and CEO of Cybex International Inc., a medical rehabilitation and cardiovascular products company. He has also served as President and Chairman of various divisions of Southam Inc., a communications group, and as Group President of the food and beverage company John Labatt Ltd.

He began his career in the health care industry with American Hospital Supply Corp. – now Baxter International Inc. – where he served for 15 years in sales, marketing, operations, business development and general management positions, leading to his appointment as President of all the Far East divisions, based in Tokyo.

He has also served on a number of boards, including AdvaMed, where he was chair of its orthopedics sector. He was a member of the Boston Scientific board of directors from 2007 until earlier this year. In addition to serving as President and CEO of Boston Scientific, he will rejoin the board. He holds a bachelor’s degree from the University of Western Ontario, Canada.

During Elliott’s leadership of Zimmer, sales and market capitalization quadrupled. Sales increased from approximately $1 billion in 1997 to approximately $4 billion in 2007.

Elliott oversaw taking Zimmer public in 2001, with an initial market capitalization of approximately $5 billion. At the time of his departure in 2007, the company’s market capitalization was more than $20 billion. In 2005 he was named “Best CEO in America” for Health Care (Medical Supplies and Devices), by Institutional Investor magazine.

In a crowded conference room full of handshaking and backslapping:

“We are delighted that Ray will be joining us as only the third CEO of Boston Scientific,” said Nicholas. “His long and proven track record in leadership positions has prepared him well for this role. Ray is an extremely capable leader with extensive experience running global health care companies. We have gotten to know Ray well as a leader and colleague in the industry, as well as from his service on our board. We are confident he offers the right combination of experience, results and talents for Boston Scientific going forward.”

“As chair of the search committee, I had the opportunity to review a number of strong candidates, and Ray stood out convincingly as our top choice,” said Ernest Mario, Ph.D., a member of the Company’s board of directors. “His experience and success leading large, complex, international companies – coupled with his specific expertise in medical devices – made him the clear selection to be Boston Scientific’s new CEO. We are very pleased that Ray will be assuming the leadership of the Company.”

“It’s an honor to follow Pete and Jim as the CEO of Boston Scientific, a company with great products and technologies, a rich pipeline creating substantial future growth potential, and of course, outstanding people,” said Elliott. “I look forward to leading the Boston Scientific team and building on the impressive tradition of delivering innovative medical solutions to patients and physicians. I am committed, as always, to creating value for them, our employees and our shareholders.”